|

TTE Improves Clinical Management of Stable Chest Pain

RECRUITINGSponsored by Tianjin Chest Hospital
Actively Recruiting
SponsorTianjin Chest Hospital
Started2025-01-01
Est. completion2030-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07063147

Summary

The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* symptomatic patients with SCP suspected of obstructive CAD.
* referred for TTE for the assessment of SCP.
* ≥18 years of age.
* signed informed consent.

Exclusion Criteria:

* acute coronary syndromes
* previous CAD or coronary revascularization
* nonsinus rhythm
* cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons

Conditions6

Coronary Artery DiseaseHeart DiseaseInvasive Coronary AngiographyMajor Adverse Cardiac EventsStable Angina PectorisTransthorcic Echocardiography

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.